Inventor · disambiguated record
Derek Welsbie
Also filed as: TRAN CHRIS · WELSBIE DEREK · WELSBIE DEREK S · WELSBIE DEREK STUART
8 granted patents·18 pending applications·140 citations·filing 2004–2025
86Inventor score
Top patents by PatentIndex Score
26 records- 0198US7709517B2Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2006·Granted May 4, 2010·99 cites·13 claims
- 0292US7718684B2Methods and materials for assessing prostate cancer therapies and compoundsUNIV CALIFORNIA·Filed 2005·Granted May 18, 2010·13 cites·13 claims
- 0391US9539259B2Compounds and methods of use thereof for treating neurodegenerative disordersUNIV JOHNS HOPKINS·Filed 2013·Granted Jan 10, 2017·18 cites·38 claims
- 0489US11013719B2Sunitinib formulations and methods for use thereof in treatment of glaucomaUNIV JOHNS HOPKINS·Filed 2019·Granted May 25, 2021·2 cites·9 claims
- 0586US10525034B2Sunitinib formulations and methods for use thereof in treatment of glaucomaUNIV JOHNS HOPKINS·Filed 2015·Granted Jan 7, 2020·5 cites·14 claims
- 0686US2024132452A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2023·Application pending·0 cites
- 0782US2023109968A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 0878US11766488B2Compositions and methods comprising improvements of CRISPR guide RNAS using the H1 promoterUNIV JOHNS HOPKINS·Filed 2017·Granted Sep 26, 2023·1 cites·19 claims
- 0978US2025333385A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2025·Application pending·0 cites
- 1075US2021238145A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2020·Application pending·0 cites
- 1175US2024336934A1Crispr/cas9-based compositions and methods for treating retinal degenerationsUNIV JOHNS HOPKINS·Filed 2023·Application pending·0 cites
- 1272US2020079741A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2019·Application pending·0 cites
- 1370US2019210974A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2018·Application pending·0 cites
- 1468US2021251959A1Sunitinib formulations and methods for use thereof in treatment of glaucomaUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1567US2022090086A1Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disordersUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 1667US2015112082A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2014·Application pending·0 cites
- 1766US2018086718A1Diarylhydantoin CompoundsUNIV CALIFORNIA·Filed 2017·Application pending·0 cites
- 1865US11180760B2Identification of molecular pathways and methods of use thereof for treating retinal neurodegeneration and other neurodegenerative disordersUNIV JOHNS HOPKINS·Filed 2013·Granted Nov 23, 2021·0 cites·6 claims
- 1963US2013034501A1Diarylhydantoin compoundsUNIV CALIFORNIA·Filed 2012·Application pending·0 cites
- 2062US2025092391A1Promoters for viral-based gene therapyUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2160US2025041451A1Gene therapy for hearing lossPERCEIVE BIOTHERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 2259US2024216537A1Gene therapy for neuroprotectionUNIV CALIFORNIA·Filed 2022·Application pending·0 cites
- 2357US8034548B2Methods and materials for assessing prostate cancer therapiesUNIV CALIFORNIA·Filed 2004·Granted Oct 11, 2011·2 cites·9 claims
- 2456US2023382904A1SUBSTITUTED 4-([1,2,4]TRIAZOLO[1,5-a]PYRIDIN-6-YL)THIOPHENE-2-CARBOXAMIDE DERIVATIVES AND USE THEREOFUNIV JOHNS HOPKINS·Filed 2021·Application pending·0 cites
- 2555US2020080108A1Crispr/cas9-based compositions and methods for treating retinal degenerationsUNIV JOHNS HOPKINS·Filed 2017·Application pending·0 cites
- 2650US2023086702A1Substituted 2-amino-pyrazolyl-[1,2,4]triazolo[1,5a]pyridine derivatives and use thereofUNIV JOHNS HOPKINS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Derek Welsbie files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →